Search Results - "Ostřížková, Lenka"

Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma by Krkoška, Martin, Nekvindová, Jana, Nevědělová, Kateřina, Zubáňová, Veronika, Radová, Lenka, Vondráček, Jan, Herůdková, Jarmila, Slabý, Ondřej, Kiss, Igor, Bohovicová, Lucia, Fabian, Pavel, Tylichová, Zuzana, Kala, Zdeněk, Kysela, Petr, Ostřížková, Lenka, Palička, Vladimír, Hyršlová Vaculová, Alena

“…Hepatocellular carcinoma (HCC) is a major contributor to the worldwide cancer burden. Recent studies on HCC have demonstrated dramatic alterations in…”
Get more information

Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma by Eid, Michal, Ostřížková, Lenka, Kunovský, Lumír, Brančíková, Dagmar, Kala, Zdeněk, Hlavsa, Jan, Janeček, Pavel, Kosíková, Ivana, Blažková, Monika, Slabý, Ondřej, Mayer, Jiří

“…Pancreatic ductal adenocarcinoma (PDAC) is now the 11th most common cancer and in 2018 there were 458,918 new cases worldwide. In the Czech Republic, a total…”
Get more information

Biomarkers as prognostic and predictive factors in patients with hepatocellular carcinoma undergoing radiological oncological interventions by Zavadil, J, Rohan, T, Juráček, J, Kiss, I, Ostřížková, L, Válek, V, Slabý, O, Andrašina, T

“…Hepatocellular carcinoma is the most common malignant liver tumor in adults and thermal ablation and transarterial embolization are important methods of…”
Get more information

Oral vinorelbine in combination with cisplatin or carboplatin in adjuvant chemotherapy of non-small cell lung cancer: A prospective multicentre study of feasibility, tolerability and 3-year survival by Kolek, Vítězslav, Grygárková, Ivona, Chalupa, Jiří, Koubková, Leona, Švecová, Jiřina, Skřičková, Jana, Ostřížková, Lenka, Sixtová, Dimka

Get full text

The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis – Randomized study by Andrasina, Tomas, Rohan, Tomas, Panek, Jiri, Kovalcikova, Petra, Kunovsky, Lumir, Ostrizkova, Lenka, Valek, Vlastimil

“…•Endobiliary RFA prior metal stent implantation is a safe method.•Endobiliary RFA improves biliary metal stent patency rate in patient with hilar…”
Get full text

Corrigendum to “The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis – Randomized study”. [Eur. J. Radiol. 142 (2021) 109830] by Andrasina, Tomas, Rohan, Tomas, Panek, Jiri, Kovalcikova, Petra, Kunovsky, Lumir, Ostrizkova, Lenka, Valek, Vlastimil

Get full text

Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization and its Impact on Overall Survival by HAJKOVA, MONIKA, ANDRASINA, TOMAS, OVESNA, PETRA, ROHAN, TOMAS, DOSTAL, MAREK, VALEK, VLASTIMIL, OSTRIZKOVA, LENKA, TUCEK, STEPAN, SEDO, JIRI, KISS, IGOR

“…BACKGROUND/AIMTo evaluate the prognostic value of Response Evaluation Criteria In Solid Tumors (RECIST), modified RECIST and volumetric analysis in patients…”
Get full text

Metastatic adeoid cystic carcinoma of the salivary gland by Brancikova, Dagmar, Protivankova, Marketa, Ostrizkova, Lenka, Mechl, Zdenek, Pejcoch, Radek

“…Abstract only…”
Get full text

Relevance of KRAS status in relation to clinical outcome of anti-VEGF-based therapy of metastatic disease in patients with right-sided primary colorectal cancer by Obermannova, Radka, Zdrazilova-Dubska, Lenka, Hejduk, Karel, Chloupkova, Renata, Vocka, Michal, Ostrizkova, Lenka, Benscikova, Beatric, Kiss, Igor, Petruzelka, Lubos

“…Abstract only 785 Background: Right-sided location of primary colorectal carcinoma is associated with worse prognosis and predicts worse outcome of treatment…”
Get full text

Molecular biological diagnostics of KRAS and BRAF mutations in patients with colorectal cancer - laboratory experience by Robešová, B, Bajerová, M, Vašíková, A, Ostřížková, L, Hausnerová, J, Kyclová, J, Pospíšilová, S, Mayer, J, Dvořáková, D

“…Targeted biological therapy based on blocking growth factor receptors and inhibition of cancer-inducing signaling pathways is a new treatment facility for…”
Get more information

Bevacizumab in the First Line Therapy of Metastatic Colorectal Cancer in Olderpatients, Study Avex in Clinical Practice by Lenka, Ostrizkova, Zdenek, Mechl, Dagmar, Brancikova, Otakar, Bednarik, Marketa, Protivankova

Get full text

Comparison of survival for left-sided KRASwt mCRC patients treated with anti-EGFR based therapy as compared to right-sided mCRC by Petruzelka, Lubos B., Obermannova, Radka, Hejduk, Karel, Ostrizkova, Lenka, Zdrazilova-Dubska, Lenka, Brancikova, Dagmar, Bencsikova, Beatrix, Vyzula, Rostislav, Vocka, Michal

“…Abstract only 763 Background: Anti-EGFR-antibody-based treatment is a standard of care in patients with RASwt metastatic colorectal cancer (mCRC). Right-sided…”
Get full text

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view by Bencsikova, Beatrix, Bortlicek, Zbynek, Halamkova, Jana, Ostrizkova, Lenka, Kiss, Igor, Melichar, Bohuslav, Pavlik, Tomas, Dusek, Ladislav, Valik, Dalibor, Vyzula, Rostislav, Zdrazilova-Dubska, Lenka

“…The aim of the present retrospective study was to analyze clinical outcome and risk factors associated with treatment outcomes according to KRAS status in…”
Get full text

Survival Length after Pancreaticoduodenectomy for Adenocarcinoma in Correlation with Preoperative CT Characteristics and Tumour Resections Margin Assesment by Kunovsky, Lumir, Prochazka, Vladimir, Kala, Zdenek, Hlavsa, Jan, Dolina, Jiri, Maskova, Hana, Senkyrik, Michal, Andrasina, Tomas, Litavcova, Alexandra, Mazanec, Jan, Ostrizkova, Lenka, Eid, Michal, Kovalcikova, Petra, Pavlik, Tomas, Dite, Petr

Get full text